MENDELSOHN D. ERIC

PrivateCIK: 1410716

Location

SEATTLE, WA

MENDELSOHN D. ERIC (CEO and President) received a stock award from NATIONAL HEALTH INVESTORS INC

Compensation award — not an open‑market transaction. Less informative as a directional signal.

A · 1 award

MENDELSOHN D. ERIC

Filed: 3/5/2025ACC: 0001127602-25-008416

InsiderMENDELSOHN D. ERICCIK 1410716

→

IssuerNATIONAL HEALTH INVESTORS INCCIK 877860

DirectorOfficer· CEO and President

Since Mar 2026

+83K

Net shares

Net buyer

$0.00

Total acquired

0

Open market trades

0B · 0S

4

Total transactions

83K acquired

Non-Derivative Transactions1

Common Stock

Direct

A · Award

Shares

+8K

Price / share

—

Trade value

—

% of position

9.0%

3/3/2025

88.53K→96.53K

Total

Net shares

+8K

Net value

$0.00

Security	Date	Type	Shares	Price / Share	Trade Value	% of Position	Held Before	Held After
Common Stock Direct	3/3/2025	A · Award	+8K	—	—	9.0%	88.53K	96.53K
Total			+8K		$0.00

Derivative Transactions3

Stock Option (Right to Buy) 2025

Direct

A · Award

Converts to

Common Stock

25K shares

Shares

+25K

Strike price

73.34

Held after

25K

Exercisable

—

3/3/2025

Stock Option (Right to Buy) 2025

Direct

A · Award

Converts to

Common Stock

25K shares

Shares

+25K

Strike price

73.34

Held after

25K

Exercisable

—

3/3/2025

Stock Option (Right to Buy) 2025

Direct

A · Award

Converts to

Common Stock

25K shares

Shares

+25K

Strike price

73.34

Held after

25K

Exercisable

—

3/3/2025

Security	Converts To	Date	Type	Shares	Strike Price	Exercisable	Held After
Stock Option (Right to Buy) 2025 Direct	Common Stock25K shares	3/3/2025	A · Award	+25K	73.34	—	25K
Stock Option (Right to Buy) 2025 Direct	Common Stock25K shares	3/3/2025	A · Award	+25K	73.34	—	25K
Stock Option (Right to Buy) 2025 Direct	Common Stock25K shares	3/3/2025	A · Award	+25K	73.34	—	25K

Non-Derivative Holdings (Post-Transaction)0

No non-derivative holdings reported

Derivative Holdings (Post-Transaction)6

Stock Options (Right to Buy) 2-25-2021

Direct

Underlying security

Common Stock

Underlying shares

41.67K

Shares owned

41.67K

Exercise price

69.20

Expiration

—

Exercise window

—

Stock Option (Right to Buy) 2024

Direct

Underlying security

Common Stock

Underlying shares

13.33K

Shares owned

13.33K

Exercise price

57.76

Expiration

—

Exercise window

—

Stock Options (Right to Buy) 2-25-2021

Direct

Underlying security

Common Stock

Underlying shares

41.67K

Shares owned

41.67K

Exercise price

69.20

Expiration

—

Exercise window

—

Stock Options (Right to Buy) 2-25-2021

Direct

Underlying security

Common Stock

Underlying shares

41.67K

Shares owned

41.67K

Exercise price

69.20

Expiration

—

Exercise window

—

Stock Option (Right to Buy) 2023

Direct

Underlying security

Common Stock

Underlying shares

13.33K

Shares owned

13.33K

Exercise price

54.73

Expiration

—

Exercise window

—

Stock Option (Right to Buy) 2024

Direct

Underlying security

Common Stock

Underlying shares

13.33K

Shares owned

13.33K

Exercise price

57.76

Expiration

—

Exercise window

—

Total

Underlying

165K

Owned

165K

Security	Underlying	Exercise Price	Exercise Window	Expiration	Underlying Shares	Shares Owned
Stock Options (Right to Buy) 2-25-2021 Direct	Common Stock	69.20	—	—	41.67K	41.67K
Stock Option (Right to Buy) 2024 Direct	Common Stock	57.76	—	—	13.33K	13.33K
Stock Options (Right to Buy) 2-25-2021 Direct	Common Stock	69.20	—	—	41.67K	41.67K
Stock Options (Right to Buy) 2-25-2021 Direct	Common Stock	69.20	—	—	41.67K	41.67K
Stock Option (Right to Buy) 2023 Direct	Common Stock	54.73	—	—	13.33K	13.33K
Stock Option (Right to Buy) 2024 Direct	Common Stock	57.76	—	—	13.33K	13.33K
Total					165K	165K